Open AccessIncidence of endophthalmitis after intravitreal Anti-vascular endothelial growth factor: Experience in Saudi Arabia
Author(s) -
Saba Al-Rashaed,
Sulaiman M. Alsulaiman,
Abdulaziz Adel Alrushood,
Jluwi Almasaud,
J. Fernando Arévalo
Publication year - 2016
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.171756
Subject(s) - medicine , endophthalmitis , ranibizumab , vitrectomy , bevacizumab , pars plana , incidence (geometry) , ophthalmology , visual acuity , surgery , evisceration (ophthalmology) , chemotherapy , physics , alternative medicine , pathology , optics
To report the incidence of endophthalmitis, the clinical and microbiological aspects, after intravitreal (IVT) injection of anti-vascular endothelial growth factor.